Form 8-K - Current report:
SEC Accession No. 0001193125-25-323787
Filing Date
2025-12-18
Accepted
2025-12-18 08:24:44
Documents
54
Period of Report
2025-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d21464d8k.htm   iXBRL 8-K 38293
2 EX-99.1 d21464dex991.htm EX-99.1 54333
6 GRAPHIC g21464ex99_1p10g1.jpg GRAPHIC 347298
7 GRAPHIC g21464ex99_1p11g1.jpg GRAPHIC 311987
8 GRAPHIC g21464ex99_1p12g1.jpg GRAPHIC 260693
9 GRAPHIC g21464ex99_1p13g1.jpg GRAPHIC 241700
10 GRAPHIC g21464ex99_1p14g1.jpg GRAPHIC 313893
11 GRAPHIC g21464ex99_1p15g1.jpg GRAPHIC 274140
12 GRAPHIC g21464ex99_1p16g1.jpg GRAPHIC 279255
13 GRAPHIC g21464ex99_1p17g1.jpg GRAPHIC 383136
14 GRAPHIC g21464ex99_1p18g1.jpg GRAPHIC 372233
15 GRAPHIC g21464ex99_1p19g1.jpg GRAPHIC 204354
16 GRAPHIC g21464ex99_1p1g1.jpg GRAPHIC 176834
17 GRAPHIC g21464ex99_1p20g1.jpg GRAPHIC 91039
18 GRAPHIC g21464ex99_1p21g1.jpg GRAPHIC 315183
19 GRAPHIC g21464ex99_1p22g1.jpg GRAPHIC 299743
20 GRAPHIC g21464ex99_1p23g1.jpg GRAPHIC 239597
21 GRAPHIC g21464ex99_1p24g1.jpg GRAPHIC 286344
22 GRAPHIC g21464ex99_1p25g1.jpg GRAPHIC 174576
23 GRAPHIC g21464ex99_1p26g1.jpg GRAPHIC 338321
24 GRAPHIC g21464ex99_1p27g1.jpg GRAPHIC 250881
25 GRAPHIC g21464ex99_1p28g1.jpg GRAPHIC 99781
26 GRAPHIC g21464ex99_1p29g1.jpg GRAPHIC 247142
27 GRAPHIC g21464ex99_1p2g1.jpg GRAPHIC 437678
28 GRAPHIC g21464ex99_1p30g1.jpg GRAPHIC 235157
29 GRAPHIC g21464ex99_1p31g1.jpg GRAPHIC 232209
30 GRAPHIC g21464ex99_1p32g1.jpg GRAPHIC 242497
31 GRAPHIC g21464ex99_1p33g1.jpg GRAPHIC 355054
32 GRAPHIC g21464ex99_1p34g1.jpg GRAPHIC 245729
33 GRAPHIC g21464ex99_1p35g1.jpg GRAPHIC 334508
34 GRAPHIC g21464ex99_1p36g1.jpg GRAPHIC 226151
35 GRAPHIC g21464ex99_1p37g1.jpg GRAPHIC 223442
36 GRAPHIC g21464ex99_1p38g1.jpg GRAPHIC 252417
37 GRAPHIC g21464ex99_1p39g1.jpg GRAPHIC 267388
38 GRAPHIC g21464ex99_1p3g1.jpg GRAPHIC 347924
39 GRAPHIC g21464ex99_1p40g1.jpg GRAPHIC 319147
40 GRAPHIC g21464ex99_1p41g1.jpg GRAPHIC 274511
41 GRAPHIC g21464ex99_1p4g1.jpg GRAPHIC 310753
42 GRAPHIC g21464ex99_1p5g1.jpg GRAPHIC 282583
43 GRAPHIC g21464ex99_1p6g1.jpg GRAPHIC 273150
44 GRAPHIC g21464ex99_1p7g1.jpg GRAPHIC 238463
45 GRAPHIC g21464ex99_1p8g1.jpg GRAPHIC 90067
46 GRAPHIC g21464ex99_1p9g1.jpg GRAPHIC 331484
  Complete submission text file 0001193125-25-323787.txt   15427149

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA howl-20251218.xsd EX-101.SCH 2518
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE howl-20251218_lab.xml EX-101.LAB 18700
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE howl-20251218_pre.xml EX-101.PRE 11689
56 EXTRACTED XBRL INSTANCE DOCUMENT d21464d8k_htm.xml XML 3862
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40366 | Film No.: 251581367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)